Centre allocates Remdesivir supply to 19 StatesUTs with high load
We Care...!!!

NEW DELHI: The central authorities on Saturday allotted provide of Remdesivir to 19 States/Union Territories with a excessive burden of Covid-19 instances.
“The escalation of serious Covid-19 patients in hospitals for effective clinical management has also resulted in an increase in the demand of Remdesivir. While the States have been advised to promote the judicious use of the drug which is listed as an Investigational Therapy by the ministry, they have also been advised to take action against possible hoarding and black marketing of the drug,” reads a well being ministry launch.
“Keeping in thoughts the sudden surge in demand within the nation for Remdesivir Injection required for Covid-19 remedy, the manufacturing capability of home Remdesivir producers has been ramped up. All assist is being prolonged to producers by the federal government on this endeavour. The manufacturing capability is being ramped up from the present stage of 38 lakh vials monthly to 74 lakh vials monthly, and 20 further manufacturing websites have been accredited. Export of Remdesivir has additionally been prohibited on April 11, 2021, so as to shore up home provides,” it added.
To additional deal with studies of shortages in sure areas of the nation and facilitate the sleek inter-state provide of Remdesivir, the Union Health Ministry in coordination with the Department of Pharmaceuticals has made an interim allocation of Remdesivir for 19 States/UTs for the interval as much as April 30, 2021.
Taking to Twitter, Union Minister Sadananda Gowda mentioned: “After detailed review of statewise allotment of #Remdesivir with @Pharmadept, substantial increase has been made in overall production & allotment to all states. This will make country’s fight stronger against #COVID19. State-wise allocation of #Remdesivir upto April 30, 2021.”
Several states throughout the nation have requested for extra provides of Remdesivir amid the file surge in Covid-19 infections.


Leave a Reply

Your email address will not be published. Required fields are marked *

Translate »